By: William A. Haseltine Antiphospholipid antibodies activity may help explain hypercoagulation associated with late stages of Covid-19 and long-haul disease. Blood samples from nearly 250 individuals hospitalized for Covid-19 found that these “rouge” antibodies activate endothelial cells, risking widespread blood clots. The activity of antiphospholipid antibodies may help explain hypercoagulation associated with late stages of […]
Mar 8
COVID Patients at Risk for 20 Cardiovascular Diseases
By: Carolyn Crist COVID Patients at Risk for 20 Cardiovascular Diseases March 4, 2022 — People who contract COVID-19 face higher risks for 20 different heart and vascular diseases after being infected, according to a new study published in Nature Medicine. Even people who weren’t hospitalized with COVID-19 developed more cardiovascular disease than those who […]
Mar 8
Opinion: These Covid-19 symptoms raise new questions
With an elevated risk of heart disease, stroke and blood clots as a possible long-term effect of Covid-19, perhaps the Veterans Affairs researchers will do something that almost a million American deaths has not: frighten a broad swath of the vaccine-hesitant into rolling up their sleeves and taking the shots, writes Kent Sepkowitz Two years […]
Mar 8
The end of inflammation? New approach could treat dozens of diseases.
By Connie Chang Cancer, aging, and severe COVID-19 have all been linked to damage from inflammation. Now scientists are flipping their focus to find new drugs that may revolutionize treatments. Growing up in Atlanta, Georgia, Lauren Finney Harden had always had allergies. But after she moved to New York City for her first job in […]
